Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience

Highlights • We report our data for oral cavity cancer treated with chemotherapy and radiation. • Actuarial 5-year overall survival was 15%. • Kaplan–Meier 5-year locoregional control: 37%. • Mucositis was the most common ⩾Grade 3 toxicity. • Adequate and early multimodality treatment needed to impr...

Full description

Saved in:
Bibliographic Details
Published inOral oncology Vol. 51; no. 7; pp. 709 - 715
Main Authors Scher, Eli D, Romesser, Paul B, Chen, Christine, Ho, Felix, Wuu, Yen, Sherman, Eric J, Fury, Matthew G, Wong, Richard J, McBride, Sean, Lee, Nancy Y, Riaz, Nadeem
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.07.2015
Subjects
Adult
Aged
Aged, 80 and over
Chemoradiotherapy - adverse effects
Chemoradiotherapy - methods
Combined Modality Therapy - methods
Definitive radiation
Deglutition Disorders - epidemiology
Female
Head and neck cancer
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
Mouth Neoplasms - mortality
Mouth Neoplasms - therapy
Mucositis - epidemiology
Oral cavity cancer
Otolaryngology
Radiation Injuries - epidemiology
Survival Analysis
Treatment Outcome
Trismus - epidemiology
Head and neck cancer
Definitive radiation
Oral cavity cancer
Online AccessGet full text

Cover

More Information
Summary:Highlights • We report our data for oral cavity cancer treated with chemotherapy and radiation. • Actuarial 5-year overall survival was 15%. • Kaplan–Meier 5-year locoregional control: 37%. • Mucositis was the most common ⩾Grade 3 toxicity. • Adequate and early multimodality treatment needed to improve outcomes.
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2015.04.007